Astrid Buxbaum
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- A. Georgopoulos (5 shared papers)Rainer Schmid (1 shared paper)Hans‐Georg Eichler (1 shared paper)Markus Müller (1 shared paper)Apostolos P. Georgopoulos (6 shared papers)W. Graninger (4 shared papers)Christina Kratzer (3 shared papers)Selma Tobudic (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)International Journal of Antimicrobial Agents (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Clinical Microbiology and Infection (1 paper)Infection (1 paper)
- Partner nations
- AustriaUnited StatesFrance
In The Last Decade
Astrid Buxbaum
15 papers receiving 330 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 37
- Pharmacology 101
- Microbiology 32
- Applied Microbiology and Biotechnology 9
- Infectious Diseases 60
Countries citing papers authored by Astrid Buxbaum
This map shows the geographic impact of Astrid Buxbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Buxbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Buxbaum more than expected).
Fields of papers citing papers by Astrid Buxbaum
This network shows the impact of papers produced by Astrid Buxbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Buxbaum. The network helps show where Astrid Buxbaum may publish in the future.
Co-authors
The 24 scholars most cited alongside Astrid Buxbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 125 | |
| 2 | 2006 | 49 | |
| 3 | 2006 | 36 | |
| 4 | 1999 | 34 | |
| 5 | 2006 | 21 | |
| 6 | 2003 | 17 | |
| 7 | 2004 | 17 | |
| 8 | 1997 | 17 | |
| 9 | 2007 | 8 | |
| 10 | 1996 | 7 | |
| 11 | 2004 | 6 | |
| 12 | 2004 | 6 | |
| 13 | 1999 | 5 | |
| 14 | Efficacy of macrolides vs. metronidazole against Entamoeba histolytica clinical isolates. | 2001 | 5 |
| 15 | 1998 | 2 |
About Astrid Buxbaum
Astrid Buxbaum is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Organic Chemistry and Molecular Medicine, having authored 15 papers that have together received 355 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial agents and applications (3 papers), Antibiotic Resistance in Bacteria (3 papers), Streptococcal Infections and Treatments (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial biofilms and quorum sensing (2 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). The work is most often cited by research in Molecular Medicine (37 citations), Pharmacology (101 citations), Microbiology (32 citations), Applied Microbiology and Biotechnology (9 citations) and Infectious Diseases (60 citations). Astrid Buxbaum has collaborated with scholars based in Austria, United States and France. Frequent co-authors include A. Georgopoulos, Rainer Schmid, Hans‐Georg Eichler, Markus Müller, Apostolos P. Georgopoulos, W. Graninger, Christina Kratzer, Selma Tobudic, Wolfgang Graninger and Christine Möser. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Clinical Pharmacology & Therapeutics, Clinical Microbiology and Infection and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.